EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Differential Proteomics of Large Extracellular Vesicles in Ovarian Cancer

Kazuhiro Suzuki, Yusuke Yamamoto, Masami Kitagawa, Eri Asano-Inami, Kosuke Yoshida, Hiroaki Kajiyama, Akira Yokoi iD

PROTEOMICS · 2026-02 · 26 (2-3) · 95-104

DOI: 10.1002/pmic.70054 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PROTEOMICS, online erschienen am 02.10.2025. Verfasst von Kazuhiro Suzuki und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Extracellular Vesicles, Proteomics, Biomarkers, Tumor. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fusion Oriented Research for disruptive Science and Technology from Japan Science and Technology Agency, JSPS KAKENHI, Project for Cancer Research and Therapeutic Evolution (P-PROMOTE).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diverse extracellular vesicles (EVs) are present in all body fluids; however, knowledge of large EVs (lEVs) remains limited. Molecular EV profiles vary depending on EV size and the physiological circulatory system, even within the same patient. In this study, we aimed to characterize the proteomic profile of IEVs in ovarian cancer patients and identify lEV‐protein biomarkers. We collected tissue, serum, and ascites from patients with high‐grade serous ovarian cancer and concurrently separated small EVs (sEVs) and lEVs through sequential multistep centrifugation. Proteomic analysis of tissues and EVs revealed distinct EV profiles in serum and ascites, identifying 11 lEV‐specific proteins in serum and 14 in ascites that were absent in sEV. Of these, seven serum‐specific and 10 ascites‐specific proteins were further analyzed using transcriptomic databases, revealing candidate diagnostic and prognostic lEV‐protein biomarkers. Our findings underscore the importance of size‐based EV separation, as particle size influences biosynthetic mechanisms, in identifying lEV‐specific proteins with potential diagnostic and prognostic values. Summary This study underscores the importance of distinguishing extracellular vesicle (EV) subtypes and considering body fluid specificity in biomarker discovery. By isolating EVs based on size and stepwise separation and analyzing their proteomic profiles in ovarian cancer, we identified potential large EV (lEV)‐specific biomarkers that reflect disease pathology. These findings provide a foundation for lEV‐protein–based liquid biopsy approaches that could enhance the accuracy of early detection and patient stratification. Further validation in clinical settings may pave the way for more precise and personalized ovarian cancer diagnostics.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ovarian NeoplasmsExtracellular VesiclesProteomicsBiomarkers, TumorProteomeFemaleHumansMiddle AgedAscites

Stichwörter der Autor:innen

biomarkerextracellular vesicleliquid biopsyovarian cancerproteomics

Substanzen

Biomarkers, TumorProteome

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Nagoya University Graduate School of Medicine, Nagoya, Aichi, Japan.
  • Laboratory of Integrative Oncology, National Cancer Center Research Institute, Tokyo, Japan.
  • Institute for Advanced Research, Nagoya University, Nagoya, Aichi, Japan.
  • Fusion Oriented Research for disruptive Science and Technology, Japan Science and Technology Agency, Kawaguchi, Saitama, Japan.

ORCID-Profile: Akira Yokoi

Förderung

  • Fusion Oriented Research for disruptive Science and Technology from Japan Science and Technology Agency
  • JSPS KAKENHI
  • Project for Cancer Research and Therapeutic Evolution (P-PROMOTE)
  • Tokai Pathways to Global Excellence as part of MEXT Strategic Professional Development Program for Young Researchers

Zitieren

APA

Suzuki, K., Yamamoto, Y., Kitagawa, M., Asano-Inami, E., Yoshida, K., Kajiyama, H., & Yokoi, A. (2026). Differential Proteomics of Large Extracellular Vesicles in Ovarian Cancer. PROTEOMICS, 26(2-3), 95-104. https://doi.org/10.1002/pmic.70054

Vancouver

Suzuki K, Yamamoto Y, Kitagawa M, Asano-Inami E, Yoshida K, Kajiyama H, et al. Differential Proteomics of Large Extracellular Vesicles in Ovarian Cancer. PROTEOMICS. 2026;26(2-3):95-104. doi:10.1002/pmic.70054

BibTeX
@article{Suzuki2026,
  author = {Suzuki, Kazuhiro and Yamamoto, Yusuke and Kitagawa, Masami and Asano-Inami, Eri and Yoshida, Kosuke and Kajiyama, Hiroaki and Yokoi, Akira},
  title = {Differential Proteomics of Large Extracellular Vesicles in Ovarian Cancer},
  journal = {PROTEOMICS},
  year = {2026},
  volume = {26},
  number = {2-3},
  pages = {95--104},
  doi = {10.1002/pmic.70054}
}
Kostenlos starten →